David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 22,732 shares at $14.59 ($332K) on 2025-07-14, disclosed to the SEC on 2025-07-15.
Scheduled sale ($332k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.59 | 11,366 | $166K | 50.0% |
| 2 | $14.59 | 11,366 | $166K | 50.0% |
| Total | $14.59 avg | 22,732 | $332K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |